alexa Gavin P Robertson | The Pennsylvania State University C
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Gavin P Robertson

The Pennsylvania State University College of Medicine, USA

Gavin P. Robertson, Ph.D. is Professor of Pharmacology, Pathology, Dermatology and Surgery at Penn State University, Director, Penn State Melanoma Center, and Director, Foreman Foundation Melanoma Research Laboratory in the Department of Pharmacology and Penn State Cancer Institute. His research focuses on malignant melanoma; the most deadly form of skin cancer, with the goal of unraveling the biology and signaling pathways involved in melanoma tumor development, and in developing the next generation of therapeutic agents to treat this disease. The discovery of Akt3 involvement in ~70% of human melanomas led to the development of ISC-4, which targets Akt3 signaling. Nanotechnology and bioengineering are enabling the use of nanoliposomes and ultrasound that deliver therapeutic products into melanoma cells, leading to the development of Nanolipolee-007. His translational research program is focused on developing better therapeutics based on the biology of the disease. He holds a Ph.D., University of California, Riverside, and completed his Postdoctoral Training at the Ludwig Institute for Cancer Research in San Diego.

Research Interest

Drug Resistance,Bone Marrow Cancer,Cancer Therapies, Nanotechnology, Nanobiotechnology, Nanocomposites, Nanobiopharmaceutics, Nanoelectronics, Nanomedicine, Nanotoxicology


Use of Nanotechnology to Develop Multi-Drug Inhibitors for Cancer Therapy

Raghavendra Gowda, Nathan R Jones, Shubhadeep Banerjee and Gavin P Robertson

Review Article: J Nanomed Nanotechnol 2013, 4:184

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version